Details for Patent: 10,300,065

Which drugs does patent 10,300,065 protect, and when does it expire?

Patent 10,300,065 protects BRILINTA and is included in one NDA.

Protection for BRILINTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has sixteen patent family members in nine countries.

Summary for Patent: 10,300,065

Title:	Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction
Abstract:	The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.
Inventor(s):	Andersson; Lars Magnus (Molndal, SE), Andersson; Tomas Lars-Gunnar (Molndal, SE), Bengtsson; Olof Fredrik (Molndal, SE), Held; Hans Peter (Molndal, SE), Howells; Garnet Edward (Edinburgh, GB), Jensen; Eva Christina (Molndal, SE), Storey; Robert (Sheffield, GB)
Assignee:	ASTRAZENECA AB (Sodertalje, SE)
Application Number:	15/546,626
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,300,065
Patent Claim Types: see list of patent claims	Use; Composition; Delivery; Dosage form;

Drugs Protected by US Patent 10,300,065

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Astrazeneca	BRILINTA	ticagrelor	TABLET;ORAL	022433-002	Sep 3, 2015		RX	Yes	No					Y
Astrazeneca	BRILINTA	ticagrelor	TABLET;ORAL	022433-001	Jul 20, 2011	AB	RX	Yes	Yes					Y

Foreign Priority and PCT Information for Patent: 10,300,065

PCT Information
PCT Filed	January 27, 2016	PCT Application Number:	PCT/IB2016/000275
PCT Publication Date:	August 04, 2016	PCT Publication Number:	WO2016/120729

International Family Members for US Patent 10,300,065

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016210973
Brazil	112017015840
Canada	2974894
China	107530363